These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22446901)

  • 21. Exophthalmos in a young woman with no graves' disease - a case report of IgG4-related orbitopathy.
    Erdei A; Steiber Z; Molnar C; Berenyi E; Nagy EV
    BMC Ophthalmol; 2018 Jan; 18(1):5. PubMed ID: 29329570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating Graves' orbitopathy.
    Dolman PJ
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):229-48. PubMed ID: 22632361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical characteristics of dysthyroid optic neuropathy].
    Elyashiv S; Skaat A; Ben Simon G; Huna-Baron R
    Harefuah; 2015 Feb; 154(2):98-102, 137. PubMed ID: 25856861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survey of common practices among oculofacial surgeons in the Asia-Pacific region: Graves' orbitopathy.
    Sundar G; Chiam N; Lun K; Koh V
    Orbit; 2014 Oct; 33(5):319-25. PubMed ID: 25121573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Endocrine orbitopathy: the present view of a clinical endocrinologist].
    Jiskra J
    Vnitr Lek; 2017; 63(10):690-696. PubMed ID: 29127744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical assessment of thyroid related orbitopathy: a review.
    Vardizer Y; Tomkins O; Briscoe D
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():186-92. PubMed ID: 20467361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Euthyroid Graves' ophthalmopathy with negative autoantibodies.
    Cakir M
    J Natl Med Assoc; 2005 Nov; 97(11):1547-9. PubMed ID: 16334503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A symposium on thyroid-associated ophthalmopathy, also known as Graves' orbitopathy at the Jules Stein Eye Institute at the University of California, Los Angeles.
    Douglas RS; Goldberg RA; Smith TJ
    Thyroid; 2008 Sep; 18(9):931. PubMed ID: 18788916
    [No Abstract]   [Full Text] [Related]  

  • 29. [Novel treatment opportunities in Graves' orbitopathy].
    Erdei A; Gazdag A; Bodor M; Berta E; Katkó M; Ujhelyi B; Steiber Z; Győry F; Urbancsek H; Barna S; Galuska L; Nagy VE
    Orv Hetil; 2014 Aug; 155(33):1295-300. PubMed ID: 25109914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiazolidinedione induced thyroid associated orbitopathy.
    Lee S; Tsirbas A; Goldberg RA; McCann JD
    BMC Ophthalmol; 2007 Apr; 7():8. PubMed ID: 17462097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?
    Penta L; Muzi G; Cofini M; Leonardi A; Lanciotti L; Esposito S
    Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural history of graves' orbitopathy after treatment.
    Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M
    Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Graves' orbitopathy].
    Eckstein A; Esser J
    Klin Monbl Augenheilkd; 2011 May; 228(5):432-8. PubMed ID: 21534176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in the management of thyroid associated orbitopathy: A promising roadmap.
    Kurian DE; Kalra S; Kapoor N
    J Pak Med Assoc; 2022 Mar; 72(3):567-571. PubMed ID: 35320248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid-Associated Orbitopathy: Management and Treatment.
    Hennein L; Robbins SL
    J Binocul Vis Ocul Motil; 2022; 72(1):32-46. PubMed ID: 34874796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management plan and delivery of care in Graves' ophthalmopathy patients.
    Yang M; Perros P
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):303-11. PubMed ID: 22632367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orbital lymphoma associated with Graves' disease: A case report.
    Hajduković Z; Kuzmić-Janković S; Kljaković-Avramović T; Sekulović L; Tukić L
    Vojnosanit Pregl; 2014 May; 71(5):510-4. PubMed ID: 26137719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Value of Multidetector Computed Tomography of Orbits in Globe Protrusion in Comparison to Hertel Exophthalmometry.
    Đorić I; Žarković M; Radojičić Z; Repac N; Janićijević A; Rotim K; Tasić G; Rasulić L
    Acta Clin Croat; 2017 Mar; 56(1):21-27. PubMed ID: 29120123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Thyroid associated orbitopathy: from diagnosis to treatment].
    Hamédani M; Obéric A
    Rev Med Suisse; 2013 Jan; 9(368):66-71. PubMed ID: 23367708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rationale for distinguishing the lipogenic form of thyroid orbitopathy].
    Brovkina AF; Iatsenko OIu
    Vestn Oftalmol; 2013; 129(2):30-4. PubMed ID: 23808177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.